94 related articles for article (PubMed ID: 16920226)
1. Effect of the C-terminus of murine S100A9 protein on experimental nociception.
Dale CS; Pagano Rde L; Paccola CC; Pinotti-Guirao T; Juliano MA; Juliano L; Giorgi R
Peptides; 2006 Nov; 27(11):2794-802. PubMed ID: 16920226
[TBL] [Abstract][Full Text] [Related]
2. The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhagin.
Dale CS; Gonçalves LR; Juliano L; Juliano MA; da Silva AM; Giorgi R
Peptides; 2004 Jan; 25(1):81-9. PubMed ID: 15003359
[TBL] [Abstract][Full Text] [Related]
3. Analgesic properties of S100A9 C-terminal domain: a mechanism dependent on calcium channel inhibition.
Dale CS; Altier C; Cenac N; Giorgi R; Juliano MA; Juliano L; Zamponi GW; Vergnolle N
Fundam Clin Pharmacol; 2009 Aug; 23(4):427-38. PubMed ID: 19515068
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain.
Paccola CC; Gutierrez VP; Longo I; Juliano L; Juliano MA; Giorgi R
Peptides; 2008 Oct; 29(10):1806-14. PubMed ID: 18582512
[TBL] [Abstract][Full Text] [Related]
5. The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2).
Dale CS; Cenac N; Britto LR; Juliano MA; Juliano L; Vergnolle N; Giorgi R
Br J Pharmacol; 2006 Oct; 149(4):374-84. PubMed ID: 16967049
[TBL] [Abstract][Full Text] [Related]
6. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
[TBL] [Abstract][Full Text] [Related]
7. The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells.
Pagano RL; Sampaio SC; Juliano L; Juliano MA; Giorgi R
Inflamm Res; 2005 May; 54(5):204-10. PubMed ID: 15953992
[TBL] [Abstract][Full Text] [Related]
8. Involvement of proteinase-activated receptors 1 and 2 in spreading and phagocytosis by murine adherent peritoneal cells: modulation by the C-terminal of S100A9 protein.
Pagano RL; Sampaio SC; Juliano MA; Juliano L; Giorgi R
Eur J Pharmacol; 2010 Feb; 628(1-3):240-6. PubMed ID: 19941849
[TBL] [Abstract][Full Text] [Related]
9. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
Marabese I; de Novellis V; Palazzo E; Scafuro MA; Vita D; Rossi F; Maione S
Neuropharmacology; 2007 Feb; 52(2):253-62. PubMed ID: 17113112
[TBL] [Abstract][Full Text] [Related]
10. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
[TBL] [Abstract][Full Text] [Related]
11. Mutual antagonism between nerve growth factor and substance P N-terminal activity on nociceptive activity in mice.
Larson AA; Kitto KF
J Pharmacol Exp Ther; 1997 Sep; 282(3):1345-50. PubMed ID: 9316845
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive action of hemopressin in experimental hyperalgesia.
Dale CS; Pagano Rde L; Rioli V; Hyslop S; Giorgi R; Ferro ES
Peptides; 2005 Mar; 26(3):431-6. PubMed ID: 15652650
[TBL] [Abstract][Full Text] [Related]
13. Neutrophilic cell-free exudate induces antinociception mediate by the protein S100A9.
Pagano RL; Mariano M; Giorgi R
Mediators Inflamm; 2006; 2006(4):36765. PubMed ID: 17047291
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
Oliveira AC; Bertollo CM; Rocha LT; Nascimento EB; Costa KA; Coelho MM
Eur J Pharmacol; 2007 Apr; 561(1-3):194-201. PubMed ID: 17343847
[TBL] [Abstract][Full Text] [Related]
15. Thermal hyperalgesia via supraspinal mechanisms in mice lacking glutamate decarboxylase 65.
Kubo K; Nishikawa K; Ishizeki J; Hardy-Yamada M; Yanagawa Y; Saito S
J Pharmacol Exp Ther; 2009 Oct; 331(1):162-9. PubMed ID: 19571163
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models.
Bertollo CM; Oliveira AC; Rocha LT; Costa KA; Nascimento EB; Coelho MM
Eur J Pharmacol; 2006 Oct; 547(1-3):184-91. PubMed ID: 16962092
[TBL] [Abstract][Full Text] [Related]
17. Roles of capsaicin-sensitive primary afferents in differential rat models of inflammatory pain: a systematic comparative study in conscious rats.
Chen HS; He X; Wang Y; Wen WW; You HJ; Arendt-Nielsen L
Exp Neurol; 2007 Mar; 204(1):244-51. PubMed ID: 17188267
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory and analgesic effects of the natural marine compound lemnalol from Formosan soft coral Lemnalia cervicorni.
Jean YH; Chen WF; Duh CY; Huang SY; Hsu CH; Lin CS; Sung CS; Chen IM; Wen ZH
Eur J Pharmacol; 2008 Jan; 578(2-3):323-31. PubMed ID: 17916350
[TBL] [Abstract][Full Text] [Related]
19. Nefopam and ketoprofen synergy in rodent models of antinociception.
Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils and the calcium-binding protein MRP-14 mediate carrageenan-induced antinociception in mice.
Pagano RL; Dias MA; Dale CS; Giorgi R
Mediators Inflamm; 2002 Aug; 11(4):203-10. PubMed ID: 12396471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
